Sensex
|
Sunday, March 13, 2011
Piramal Life Sciences Ltd: Disclosures under Reg. 3(3) of SEBI (SAST) Regulations, 1997
Paramount Pharma Pvt Ltd has submitted the disclosure under Regulation 3(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment